SCHEMBL2430675

SCHEMBL2430675

Nc1[nH]cc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
HSD17B10 Q99714 6/20 0.42
TSHR P16473 3/20 0.42
HPGD P15428 3/20 0.42
CYP3A4 P08684 1/20 0.42
KEAP1 Q14145 1/20 0.42
TDP1 Q9NUW8 2/20 0.39
CYP2A6 P11509 2/20 0.39
PARP1 P09874 1/20 0.37
F12 P00748 1/20 0.37
PLAU P00749 1/20 0.37
NCF1 P14598 1/20 0.37
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
BACE1 P56817 1/20 0.37
HPRT1 P00492 2/20 0.36
KDM4E B2RXH2 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
GLA P06280 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3915075 0.82 MAPK1 (0.41) ALDH1A1HSD17B10HPGDKDM4EGLA
SCHEMBL1672648 0.74 ALDH1A1 (0.43) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL23931683 0.72 ALDH1A1 (0.41) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL2007326 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL291458 0.70 PARP1 (0.41) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL3034404 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL10772733 0.70 ALDH1A1 (0.47) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL7137927 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10TSHRHPGDCYP3A4
SCHEMBL7775030 0.70 CYP1A2 (0.42) ALDH1A1HSD17B10TSHRTDP1CYP2A6
SCHEMBL28421357 0.70 ALDH1A1 (0.39) ALDH1A1HSD17B10TSHRHPGDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117917402-A Isoindolylamide compound, and pharmaceutical composition and application thereof 暨南大学 2024-04-23 CN claimed
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN claimed
EP-2367814-A1 NEW COMPOUNDS 578 AstraZeneca AB (SE) 2011-09-28 EP claimed
WO-2010056196-A1 NEW COMPOUNDS 578 ASTRAZENECA AB (SE) 2010-05-20 WO claimed
CN-117917402-A Isoindolylamide compound, and pharmaceutical composition and application thereof 暨南大学 2024-04-23 CN disclosed
CN-117917402-A Isoindolylamide compound, and pharmaceutical composition and application thereof 暨南大学 2024-04-23 CN disclosed
CN-115942958-A Phthalocyanine dye compounds, conjugates and methods of use thereof 乐天医药生技股份有限公司 2023-04-07 CN disclosed
CN-108997194-B Synthesis method of aminoisoindole derivative 温州大学 2021-09-14 CN disclosed
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN disclosed
CN-102592040-B The method of drug discovery 基德姆生物科学有限公司 2016-12-21 CN disclosed
WO-2011142716-A1 NOVEL HEMIFUMARATE SALT OF ISOINDOLE COMPOUND ACTING AS BACE INHIBITOR ASTRAZENECA AB (SE) 2011-11-17 WO disclosed
EP-2367814-A1 NEW COMPOUNDS 578 AstraZeneca AB (SE) 2011-09-28 EP disclosed
WO-2010056196-A1 NEW COMPOUNDS 578 ASTRAZENECA AB (SE) 2010-05-20 WO disclosed
EP-2035378-A1 SUBSTITUTED ISOINDOLES AS BACE INHIBITORS AND THEIR USE AstraZeneca AB (SE) 2009-03-18 EP disclosed
WO-2007149033-A1 SUBSTITUTED ISOINDOLES AS BACE INHIBITORS AND THEIR USE ASTRAZENECA AB (SE) 2007-12-27 WO disclosed
WO-2002000651-A2 FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-01-03 WO disclosed
EP-0991638-A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-04-12 EP disclosed
WO-1998057951-A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-12-23 WO disclosed
US-5237045-A Heat-resistant polytriazines using acid salts of aromatic amines as catalysts for aromatic tetracyano monomers; kinetics THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1993-08-17 US disclosed